Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Thyroid Cancer
- Thyroid Carcinoma
- Papillary Thyroid Carcinoma
- External Beam Radiotherapy
- Radiat Oncol Biol Phys
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Adamietz IA, Schiemann MS, Petkauskas JG, Schemmann F, Bottcher HD (1998) Prognostic factors and the effect of radiotherapy in the treatment of differentiated thyroid carcinomas. Strahlenther Onkol 174:618–623
Bal C, Padhy AK, Jana S, Pant GS, Basu AK (1996) Prospective randomised clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma. Cancer 77:2574–2580
Belin RM, Ladenson PW, Robinson KA, Powe NR (2002) Development and use of evidence-based clinical practice guidelines for thyroid disease. Endocrinol Metab Clin North Am 31:795–817
Biermann M, Nofer JR, Riemann B, Lu J, Wilde J, Schober O (2004) Clinical evaluation of a new highly sensitive thyroglobulin assay (Nichols Advantage) in 99 patients with differentiated thyroid cancer (DTC) after total thyroidectomy (abstract). Clin Chem 50: A73
Biermann M, Pixberg MK, Schober O (2003) Changing patterns of care for locally advanced differentiated thyroid carcinoma (DTC) in German-speaking Europe since 1996 (abstract). Eur J Nucl Med 30:S155
Biermann M, Pixberg MK, Schuck A, Heinecke A, Köpcke W, Schmid KW, Dralle H, Willich N, Schober O, for the MSDS study group (2003) Multicenter Study Differentiated Thyroid Carcinoma (MSDS): diminished acceptance of adjuvant external beam radiotherapy for differentiated thyroid carcinoma. Nuklearmedizin 42:244–250
Biermann M, Schober O (2002) GCP-compliant management of the Multicentric Study Differentiated Thyroid Carcinoma (MSDS) with a relational database under Oracle 8i. Inform Biom Epidemiol Med Biol 33:441–459
Biermann M, Schober O (2003) Should High hTG levels in absence of iodine uptake be treated? Eur J Nucl Med 30:160–163
Biermann M, Schober O (2002) How many high-risk patients with differentiated thyroid carcinoma does a “tumor center” need per year? (Editorial) Nuklearmedizin 41:61–62
Brearley MJ, Hayes AM, Murphy S (1999) Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: a retrospective analysis of survival. J Small Anim Pract 40:206–210
Brierley JD, Tsang RW (1999) External-beam radiation therapy in the treatment of differentiated thyroid cancer. Semin Surg Oncol 16:42–49
Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B (1993) Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626–1631
Chebotareva ED, Shishkina VV, Siniuta BF, Dzhuzha DA, Cheren'ko SM, Sheptukha AI, Gorobeiko MB, Ivanov NA (2002) Analysis of efficacy of complex treatment of patients with differentiated forms of the thyroid gland cancer using distant radiation therapy. Klin Khir pp 25–28
Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, Tong CC, Wong IS, Lau WH (2002) Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 52:784–795
Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH (2002) Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488–498
Chung CT, Sagerman RH, Ryoo MC, King GA, Yu WS, Dalai PS, Emmanuel IG (1980) External irradiation for malignant thyroid tumors. Radiology 136:753–756
Deutsche Krebsgesellschaft (2002) Malignant thyroid tumors. In: Concise interdisciplinary guidelines 2002. Zuckschwerdt, Germering
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Eichhorn W, Tabler H, Lippold R, Lochmann M, Schreckenberger M, Bartenstein P (2003) Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution. Thyroid 13:949–958
Esik O, Nemeth G, Eller J (1994) Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observational period. Oncology 51:372–379
Farahati J, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, Sack H (1996) Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 77:172–180
Foote RL, Brown PD, Garces YI, McIver B, Kasperbauer JL (2003) Is there a role for radiation therapy in the management of Hurthle cell carcinoma? Int J Radiat Oncol Biol Phys 56:1067–1072
Ford D, Giridharan S, McConkey C, Hartley A, Brammer C, Watkinson JC, Glaholm J (2003) External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 15:337–341
Gimm O, Rath FW, Dralle H (1998) Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 85:252–254
Glanzmann C, Horst W (1979) Treatment and prognosis of follicular and papillary thyroid carcinoma. Strahlentherapie 155:223–229
Glanzmann C, Lütolf UM (1992) Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment. Strahlenther Onkol 168:260–269
Glanzmann C, Lütolf UM (1992) Papillary and follicular thyroid carcinoma: Long-term follow-up of 339 patients at Zurich University Hospital between 1960 and 1988, and review. Schweiz Rundsch Med 81:457–467
Hare HF (1941) Radiation treatment of carcinoma of the thyroid. Am J Roentgenol 46:451–453
Harmer C, Bidmead M, Shepherd S, Sharpe A, Vini L (1998) Radiotherapy planning techniques for thyroid cancer. Br J Radiol 71:1069–1075
Harmer CL (1977) External beam radiotherapy for thyroid cancer. Ann Radiol Paris 20:791–800
Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885
Hedinger C, Williams ED, Sobin LH (1989) The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63:908–911
Heinze HG, Schmeis E (1976) Malignome der Schilddrüse. Behandlungsergebnisse bei 305 Patienten. Strahlentherapie 152:114
Hölzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK, Hundahl SA (2000) Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. Cancer 89:192–201
Hölzer S, Steiner D, Bauer R, Reiners C, Farahati J, Hundahl SA, Dudeck J (2000) Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany. Eur J Nucl Med 27:1465–1472
Hundahl SA, Cady B, Cunningham MP, Mazzaferri EL, McKee R, Rosai J, Shah JP, Fremgen AM, Stewart AK, Hölzer S (2000) Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer 89:202–217
Jacobson F (1954) Treatment of carcinoma of the thyroid. Acta Radiol 41:169–192
Jarzab B (2001) Indications for adjuvant therapy of thyroid cancer with radioiodine therapy. Wiad Lek 54[Suppl 1]:254–265
Kim S, Wei JP, Braveman JM, Brams DM (2004) Predicting outcome and directing therapy for papillary thyroid carcinoma. Arch Surg 139:390–394
Kim TH, Yang DS, Jung KY, Kim CY, Choi MS (2003) Value of external irradiation for locally advanced papillary thyroid cancer. Int J Radiat Oncol Biol Phys 55:1006–1012
Kleinert G (1989) Results of external beam radiotherapy for thyroid cancer. Radiobiol Radiother 30:473–480
Kuijpens JL, Hansen B, Hamming JF, Ribot JG, Haak HR, Coebergh JW(1998) Trends in treatment and long-term survival of thyroid cancer in southeastern Netherlands, 1960–1992. Eur J Cancer 34:1235–1241
Kumar H, Daykin J, Holder R, Watkinson JC, Sheppard MC, Franklyn JA (2001) An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings. Clin Endocrinol (Oxf) 54:719–723
Lee D, Cosmatos D, Marcial V (1995) Results of an RTOG phase III trial (RTOG 85–27) comparing radiotherapy plus etonidazole with radiotherapy alone for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 32:567–576
Leisner B, Degelmann G, Dirr W, Kanitz W, Bull U, Langhammer H, Lissner J, Pabst HW (1982) Therapeutic results of malignant goiter 1960–1980. Significance of percutaneous radiotherapy in well differentiated carcinomas. Dtsch Med Wochenschr 107:1702–1707
Lerch H, Schober O, Kuwert T, Saur HB (1997) Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067–2075
Li WB, Friedland W, Pomplun E, Jacob P, Paretzke HG, Lassmann M, Reiners C (2001) Track structures and dose distributions from decays of (131)I and (125)I in and around water spheres simulating micrometastases of differentiated thyroid cancer. Radiat Res 156:419–429
Lin JD, Liou MJ, Chao TC, Weng HF, Ho YS (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocr Relat Cancer 6:109–115
Mabille JP (1961) Résultats thérapeutiques des cancers throidiens. Ann Radiol 4:477–491
Maxon HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD (1992) Radioiodine-131 therapy for well-differentiated thyroid cancer — a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132–1136
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428
Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Endocrinol Metab 86:1447–1463
Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 70:511–518
Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56:171–96
Müller-Gärtner H-W, Brzac HT, Rehpenning W (1991) Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67:1903–1911
Nakashima T, Yano G, Nomura Y, Tomita K, Wada S, Hata K (1994) Use of a remote controlled radiotherapy afterloading system to manage unresectable, metastatic thyroid cancer in the trachea. Eur Arch Otorhinolaryngol 251[Suppl 1]:S73–S75
Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, Dearnaley DP, Webb S (2001) Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60:173–180
O'Connell ME, RP AH, Harmer CL (1994) Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital. Eur J Cancer 30A:733–739
Pack L, Roberts RE, Dawson SD, Dookwah HD (2001) Definitive radiation therapy for infiltrative thyroid carcinoma in dogs. Vet Radiol Ultrasound 42:471–474
Pape E (2002) External beam radiotherapy for medullary carcinoma with metastases. In: Feldkamp J, Scherbaum WA (eds) Medullary thyroid cancer. De Gruyter, Berlin, pp 83–63
Pemberton JdJ, Black BM (1939) Malignant lesions of the thyroid gland: review of 774 cases. Surg Gynaecol Obstet 69:417–430
Phlips P, Hanzen C, Andry G, van Houtte P, Fruuling J (1993) Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 19:399–404
Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J (1995) Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Endocrinol Metab 80:1488–1492
Pollinger B, Duhmke E (2001) External radiotherapy of thyroid cancer. Onkologie 24:134–138
Portmann UV (1941) Experience in the treatment of malignant tumors of the thyroid gland. Am J Roentgenol 46:454–466
Puskás C, Biermann M, Willich N, Schober O (2001) Percutaneous radiation therapy. In: Biersack H-J, Grünwald F (eds) Thyroid cancer. Springer, Berlin Heidelberg New York, pp 121–129
Reiners C (2003) Radioiodtherapie des differenzierten Schilddrüsenkarzinoms. Arzneimitteltherapie 2:39–47
Reinhardt M, Guttenberger R, Slanina J, Frommhold H, Moser E (1995) Indications for external beam radiotherapy in thyroid carcinoma. The Freiburg consensus. Radiologe 35:535–539
Rossi RL, Cady B, Silverman M, Wool S, ReMine SG, Hodge MB, Salzman FA (1988) Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy. Arch Surg 123:569–574
Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG (1992) The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1,599 patients. J Clin Endocrinol Metab 75:714–720
Sautter-Bihl ML, Heinze HG (1992) External radiotherapy of differentiated thyroid carcinoma. Dtsch Med Wochenschr 117:665–668
Sautter-Bihl ML, Herbold G, Heinze HG, Bihl H (1991) Postoperative external beam radiation in differentiated thyroid cancer: situations in which radioiodine is insufficient? Some dosimetric considerations with Monte Carlo techniques. Strahlenther Onkol 167:267–272
Sautter-Bihl M-L, Raub J, Hetzel-Sesterheim M, Heinze HG (2001) Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients. Strahlenther Onkol 177:125–131
Scheumann GFW, Dralle H (1992) External radiotherapy of differentiated thyroid carcinoma (letter). Dtsch Med Wochenschr 117:1576–1577
Schlumberger M, Challeton C, de Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases of differentiated thyroid carcinoma. J Nucl Med 37:398–605
Schlumberger M, Pacini F (2003) Thyroid tumors. Éditions Nucléon, Paris
Schuck A, Biermann M, Müller S, Schober O, Willich N (2001) Adjuvant percutaneous radiotherapy in the treatment of differentiated thyroid cancer. Nuklearmediziner 24:225–229
Schuck A, Biermann M, Pixberg MK, Müller S, Schober O, Willich N (2003) Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid cancer: First results of the Multicenter Study Differentiated Thyroid Cancer (MSDS). Strahlenther Onkol 179:821–827
Schümichen C, Schmitt E, Scheuffele C, Blattmann H, Pauli-Harnasch C (1983) Einfluss des Therapiekonzepts auf die Prognose des Schilddrüsenkarzinoms. Nuklearmedizin 23:87–105
Seegenschmidt MH, Sauer R (1993) The systematics of acute and chronic radiation sequelae. Strahlenther Onkol 169:83–95
Seegenschmiedt MH, Sautter-Bihl ML, Schmitt G, Willich N, Müller R-P (1998) Guidelines in radiooncology. External beam radiotherapy of malignant struma. AWMF-Guideline registry no. 052/001. http://www.awmf-online.de
Sheline GE, Galante M, Lindsay S (1966) Radiation therapy in the control of persistent thyroid cancer. Am J Roentgenol 97:923–930
Simpson WJ (1990) Radioiodine and radiotherapy in the management of thyroid cancers. Otolaryngol Clin North Am 23:509–521
Simpson WJ, Carruthers JS (1978) The role of external radiation in the management of papillary and follicular thyroid cancer. Am J Surg 136:457–460
Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB (1988) Papillary and follicular thyroid cancer: impact of treatment in 1,578 patients. Int J Radiat Oncol Biol Phys 14:1063–1075
Simpson WJ, Sutcliffe SB, Gospodarowicz MK (1994) The thyroid. In: Cox JD (ed) Mossʻ radiation oncology: rationale, technique, results, 7th edn. Mosby International, St. Louis, pp 280–304
Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA (1998) Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 8:215–21
Smedal MI, Salzman FA, Meissner WA (1967) The value of 2 mV roentgen-ray therapy in differentiated thyroid carcinoma. Am J Roentgenol Radium Ther Nucl Med 99:352–364
Sugg SL, Ezzat S, Rosen IB, Freeman JL, Asa SL (1998) Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Endocrinol Metab 83:4116–4122
Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B et al (1998) Outcome after treatment of high-risk papillary and non-Hurthlecell follicular thyroid carcinoma. Ann Intern Med 129:622–627
Theon AP, Marks SL, Feldman ES, Griffey S (2000) Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J Am Vet Med Assoc 216:1775–1779
Thomusch O, Dralle H (2000) Endocrine surgery and evidence-based medicine. Chirurg 71:635–645
Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB (1998) The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82:375–388
Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D (1985) External radiotherapy in thyroid cancers. Cancer 55:2062–2071
Tubiana M, Tacour J, Monnier J, Bergiron C, Gerard-Marchand R, Roujeau J, Bok B, Parmentier C (1975) External radiotherapy and radioiodine in the treatment of 359 thyroid cancers. Br J Radiol 48:894–907
Udelsman R, Lakatos E, Landenson P (1996) Optimal surgery for papillary thyroid carcinoma. World J Surg 20:88–93
Windeyer BW (1954) Cancer of the thyroid and radiotherapy. Br J Radiol 27:537–552
Wittekind C, Wagner G (1997) TNM classification of malignant tumors. Springer, Berlin Heidelberg New York
Wu XL, Hu YH, Li QH, Guo JR, Sun D, Yan JH, Xu GZ, Qin DX, Ha XW, Gu XZ (1987) Value of postoperative radiotherapy for thyroid cancer. Head Neck Surg 10:107–112
Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG (1980) Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 21:733–737
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Biermann, M., Pixberg, M., Schuck, A., Willich, N., Heinecke, A., Schober, O. (2005). External Beam Radiotherapy. In: Biersack, HJ., Grünwald, F. (eds) Thyroid Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27845-1_8
Download citation
DOI: https://doi.org/10.1007/3-540-27845-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22309-2
Online ISBN: 978-3-540-27845-0
eBook Packages: MedicineMedicine (R0)